Pharmaceutical Business review

Mylan to supply ARV drugs to Indian AIDS control organization

Mylan CEO Heather Bresch said Mylan’s mission is to provide the world’s 7 billion people access to medicines and help ensure access to ARVs.

”Only through access to these vital medicines can we stem the tide of HIV/AIDS in India and around the world,” Bresch added.

NACO is a division of India’s Ministry of Health and Family Welfare responsible for monitoring HIV/AIDS control programs in India.

NACO manages 35 HIV Prevention and Control Societies that implement NACO’s programs at the state level and manage more than 350 ARV treatment centers.